Robotics Transforms Cell Therapy: Multiply Labs Drives Staggering 74% Cost Reduction, Unlocking Global Patient Access Breakthrough partnership with Universal Robots transforms "artisanal" ...

Automating the use of market-leading, cGMP-compliant ancillary materials in cell therapy manufacturing has the potential to radically increase efficiency and throughput, without the need for ...

Multiply Labs , a robotics company, has developed a new robotic biomanufacturing cluster that achieves“a 74 percent cost reduction” for life-saving cell therapies. This breakthrough, published in peer ...

What keeps leukemia cells alive almost forever, able to continue dividing endlessly and aggressively? New research at the Weizmann Institute suggests that, in around ...

Chloride ion flows that enter the cells play an important role in the duplication of glioblastoma cells, a highly aggressive brain tumor. This is the finding of research recently published in the ...

Breakthrough partnership with Universal Robots transforms "artisanal" manufacturing, making personalized, life-saving cancer treatments affordable and widely available. "Historically, cell and gene ...

Breakthrough partnership with Universal Robots transforms "artisanal" manufacturing, making personalized, life-saving cancer treatments affordable and widely available. Leveraging collaborative robots ...

Multiply Labs, a pioneering robotics company, has developed a new robotic biomanufacturing cluster that achieves a 74% cost reduction for life-saving cell therapies. This breakthrough, published in ...